PND10 COST EFFECTIVENESS ANALYSES OF RUFINAMIDEVS TOPIRAMATE AND LAMOTRIGINE AS ADJUNCTIVE THERAPIES IN THE TREATMENT OF LENNOX-GASTAUT SYNDROME (LGS) IN THE UNITED KINGDOM
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65348-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65348-X/fulltext
Title :
PND10 COST EFFECTIVENESS ANALYSES OF RUFINAMIDEVS TOPIRAMATE AND LAMOTRIGINE AS ADJUNCTIVE THERAPIES IN THE TREATMENT OF LENNOX-GASTAUT SYNDROME (LGS) IN THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65348-X&doi=10.1016/S1098-3015(10)65348-X
First page :
Section Title :
Open access? :
No
Section Order :
507